QuintilesIMS Real-World Insights Bibliography

Impact of A Pharmacist Medication Adherence Consultation Program on Health Care Costs and Risk of Hospitalization
Author(s): Wade R.L.1, Hill J.W.1, Akinbosoye O.2, Jiang Z.2, Mu Y.2, Sun K.1, Karkare S3, Taitel M.S.2
Affiliations(s): 1IMS Health, Plymouth Meeting, PA, USA, 2Walgreen Co., Deerfield, IL, USA, 3IMS Health,Deerfield, IL, USA
Publication(s): VALUE IN HEALTH. 2015. 18(3):A3
Document Type(s): Podium presentation
Countries: USA
Click here for the abstract
C:
Y:
Medication compliance
2017
  L:
A:
English
Retrospective database analysis, Survey research
  Add to report
 
 
METHODOLOGICAL REVIEW OF SURVIVAL MODELS: APPLICATION TO A PERSISTENCE ANALYSIS BASED ON LONG ACTING PARENTERAL ANTIPSYCHOTIC IN RETAIL PHARMACIES IN FRANCE
Author(s): Harmand S, El Mouaddin N
Affiliations(s): IMS Health France
Publication(s): 19th ISPOR COngress 2016
Document Type(s): Abstract, Poster
Countries: France
C:
Y:
Medication compliance, Methodology
2016
  L:
A:
English
Compliance, Database Study, Methodology
  Add to report
 
 
Canadian Study of Outcomes in HUMIRA® (Adalimumab) Patients with Support for Adherence - Dermatology Results from the COMPANION Study
Author(s): Shear N1,2, Bessette L3, Marshall JK4, Lebovic G5,6, Gerega S7, Millson B7, Gaetano T8, Gazel S8, Latour M8, Laliberté MC8
Affiliations(s): 1 Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada 2 Department of Medicine, Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada 3 Department of Medicine, Laval University, Quebec City, Quebec, Canada; 4Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute; McMaster University, Hamilton, Ontario, Canada 5 Applied Health Research Centre, St. Michael’s Hospital, Toronto, Ontario, Canada 6 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada 7 IMS Brogan, Kirkland, Quebec, Canada 8 AbbVie Corporation, St. Laurent, Quebec, Canada
Publication(s): Dermatology Update 2016 Annual Meeting, November 3-6, Montreal, Canada
Document Type(s): Poster
Countries: Canada
Click here for the abstract
C:
Y:
Dermatology, Medication compliance
2016
  L:
A:
English
Database Study
  Add to report
 
 
Canadian Study of Outcomes in HUMIRA® (Adalimumab) Patients with Support for Adherence - Results from the COMPANION Study
Author(s): Latour M1, Gerega S2, Millson B2, Bessette L3, Marshall JK4, Lebovic G5,6, Sung M2, Oraichi D2, Gaetano T1, Gazel S1, Laliberté MC1
Affiliations(s): 1 AbbVie Corporation, St. Laurent, Quebec, Canada 2 IMS Brogan, Kirkland, Quebec, Canada 3 Department of Medicine, Laval University, Quebec City, Quebec, Canada 4 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada 5 Applied Health Research Centre, St. Michael’s Hospital, Toronto, Ontario, Canada 6 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada
Publication(s): American College of Gastroenterology 2016 Conference, October 14-19, Las Vegas, USA
Document Type(s): Poster
Countries: Canada
Click here for the abstract
C:
Y:
Gastrointestinal disorders, Medication compliance
2016
  L:
A:
English
Database Study
  Add to report
 
 
Canadian Study of Outcomes in HUMIRA® (Adalimumab) Patients with Support for Adherence - Results from the COMPANION Study
Author(s): Gerega S1, Millson B1, Bessette L2, Marshall JK3, Lebovic G4,5, Sung M1, Oraichi D1, Gaetano T6, Gazel S6, Latour M6, Laliberté MC6
Affiliations(s): 1 IMS Brogan, Kirkland, Quebec, Canada 2 Department of Medicine, Laval University, Quebec City, Quebec, Canada 3 Department of Medicine, Division of Gastroenterology, Farncombe Family Digestive Health Research Institute; McMaster University, Hamilton, Ontario, Canada 4 Applied Health Research Centre, St. Michael’s Hospital, Toronto, Ontario, Canada 5 Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada 6 AbbVie Corporation, St. Laurent, Quebec, Canada
Publication(s): American College of Rheumatology 2016 Annual Meeting, November 11-16, Washington DC, USA
Document Type(s): Poster
Countries: Canada
Click here for the abstract
C:
Y:
Medication compliance, Rheumatology
2016
  L:
A:
English
Database Study
  Add to report
 
 
Improving Medication Adherence and Health Care Outcomes in a Commercial Population through a Community Pharmacy.
Author(s): Akinbosoye OE1, Taitel MS1, Grana J1, Hill J2, Wade RL2.
Affiliations(s): 1 Walgreen Co., Health Analysis Research and Reporting , Deerfield, Illinois. 2 IMS Health, Health Economics and Outcomes Research , Real World Solutions, Plymouth Meeting, Pennsylvania.
Publication(s): Popul Health Manag. 2016 Dec;19(6):454-461
Document Type(s): Article
Countries: USA
Click here for the abstract
C:
Y:
Medication compliance
2016
  L:
A:
English
Budget impact, Retrospective database analysis
  Add to report
 
 
Improving Medication Adherence and Health Care Outcomes in a Commercial Population through a Community Pharmacy.
Author(s): Akinbosoye OE1, Taitel MS1, Grana J1, Hill J2, Wade RL2.
Affiliations(s):  1 Walgreen Co., Health Analysis Research and Reporting , Deerfield, Illinois. 2 IMS Health, Health Economics and Outcomes Research , Real World Solutions, Plymouth Meeting, Pennsylvania.
Publication(s): Popul Health Manag. 2016 Dec 1; 19(6): 454–461.
Document Type(s): Article
Countries: USA
C:
Y:
Medication compliance
2016
  L:
A:
English
Budget impact, Retrospective database analysis
  Add to report
 
 
Exploring innovative methods to identify patient subgroup treatment response
Author(s): J Rigg, M Hankins, A Roddam, A Avorn, J Kim
Affiliations(s): 
Publication(s): 31st International Conference on Pharmacoepidemiology & Therapeutic Risk Management August 22-26, 2015. Hynes Convention Center Boston, MA USA.
Document Type(s): Conference
Countries: England
C:
Y:
Medication compliance, Methodology
2015
  L:
A:
English
Methodology, Observational study
  Add to report
 
 
Adherence and cost in multiple sclerosis patients treated with IM IFN beta-1a: impact of the CARE patient management program.
Author(s): Katsarava Z1,2, Ehlken B3, Limmroth V4, Taipale K5, Patel SN5, Niemczyk G5, Rehberg-Weber K5, Wernsdörfer C5; C.A.R.E. Study Group
Affiliations(s): 1 Department of Neurology, Evangelic Hospital Unna, Unna, Germany 2 Department of Neurology, University Hospital Essen, Essen, Germany 3 IMS HEALTH, Munich, Germany 4 Department of Neurology, Cologne City Hospitals, University of Cologne, Cologne, Germany 5 Biogen GmbH, Ismaning, Germany
Publication(s): BMC Neurol. 2015 Sep 22;15(1):170.
Document Type(s): Article
Countries: Germany
Click here for the abstract
C:
Y:
Medication compliance, Neurological disorders
2015
  L:
A:
German
Cost analysis, Observational study, Prospective study
  Add to report
 
 
Analysis of Etanercept Treatment Patterns and Reimbursement Gaps in Patients Transitioning From Private to Public Drug Plans (poster)
Author(s): Millson B1, Poulin-Costello M2, Garces K2
Affiliations(s): 1 IMS Health Canada Inc, Kirkland, QC, Canada 2 Amgen Canada, Mississauga, ON, Canada
Publication(s): ISPOR Annual International Meeting 2015
Document Type(s): Poster
Countries: Canada
Click here for the abstract
C:
Y:
Medication compliance
2015
  L:
A:
English
Retrospective cohort analysis
  Add to report
 
 
 1 of 4 Next Page Last Page